Barclays PLC Oramed Pharmaceuticals Inc. Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Barclays PLC holds 13,239 shares of ORMP stock, worth $33,362. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,239

Previous 13,239 -0.0%

Holding current value

$33,362

Previous $30,000 30.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$1.71 - $2.57 $8,835 - $13,279	-5,167 Reduced 28.07%	13,239 $30,000
Q3 2023 Nov 07, 2023	BUY	$2.51 - $3.55 $12,969 - $18,342	5,167 Added 39.03%	18,406 $47,000
Q2 2023 Aug 03, 2023	SELL	$2.12 - $4.47 $15,709 - $33,122	-7,410 Reduced 35.89%	13,239 $47,000
Q1 2023 May 04, 2023	SELL	$1.93 - $13.1 $36,918 - $250,589	-19,129 Reduced 48.09%	20,649 $45,000
Q4 2022 Feb 13, 2023	BUY	$6.21 - $12.03 $113,239 - $219,367	18,235 Added 84.64%	39,778 $478,000

Q3 2022 Nov 03, 2022	BUY	$4.6 - $9.91 $7,930 - $17,084	1,724 Added 8.7%	21,543 $140,000
Q2 2022 Aug 12, 2022	SELL	$3.72 - $9.0 $24,217 - $58,590	-6,510 Reduced 24.73%	19,819 $90,000
Q1 2022 May 16, 2022	SELL	$8.19 - $13.89 $233,849 - $396,601	-28,553 Reduced 52.03%	26,329 $227,000
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $308,145 - $706,265	23,740 Added 76.23%	54,882 $783,000
Q3 2021 Nov 09, 2021	SELL	$12.13 - $23.82 $64,762 - $127,174	-5,339 Reduced 14.64%	31,142 $685,000
Q2 2021 Aug 13, 2021	BUY	$8.34 - $14.59 $133,423 - $233,410	15,998 Added 78.1%	36,481 $488,000
Q1 2021 May 13, 2021	BUY	$4.22 - $11.33 $70,305 - $188,757	16,660 Added 435.78%	20,483 $208,000
Q4 2019 Feb 10, 2020	SELL	$2.43 - $5.74 $90,821 - $214,532	-37,375 Reduced 90.72%	3,823 $20,000
Q3 2019 Nov 14, 2019	BUY	$2.88 - $3.96 $34 - $47	12 Added 0.03%	41,198 $131,000
Q3 2017 Nov 14, 2017	BUY	$7.74 - $10.78 $318,779 - $443,985	41,186	41,186 $409,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

5.69M

Call Options Held

8.3K

Put Options Held

2.7K

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $97.8M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account